Knight Therapeutics Inc.
TSX:GUD.TO
5.22 (CAD) • At close November 14, 2024
Overview | Financials
Numbers are in millions (except for per share data and ratios) CAD.
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating Activities: | ||||||||||
| Net Income
| -16.835 | -29.892 | 15.675 | 31.76 | 18.033 | 24.079 | 17.244 | 18.56 | 34.167 | 125.859 |
| Depreciation & Amortization
| 50.397 | 62.621 | 47.915 | 32.075 | 4.27 | 1.932 | 1.629 | 0.437 | 0.124 | 0.085 |
| Deferred Income Tax
| -9.126 | -17.125 | -7.636 | -2.012 | 0.913 | 1.85 | 2.058 | 0.723 | 0.91 | 0.772 |
| Stock Based Compensation
| 2.327 | 1.888 | 3.045 | 1.95 | 2.137 | 2.17 | 3.038 | 3.64 | 4.421 | 1.805 |
| Change In Working Capital
| -28.013 | -9.989 | 0.627 | -21.607 | -12.199 | -23.338 | 3.05 | -3.462 | -3.818 | 4.51 |
| Accounts Receivables
| 5.575 | -26.418 | 8.593 | 20.106 | -10.403 | -2.58 | -3.201 | -3.446 | -1.97 | -0.741 |
| Inventory
| 0.698 | -11.428 | -17.188 | 9.709 | 8.146 | 0.088 | -0.434 | 0.67 | -0.858 | -0.602 |
| Accounts Payables
| -21.629 | 30.601 | 11.455 | -46.856 | 10.68 | 1.075 | 1.818 | 1.943 | 0.326 | 1.644 |
| Other Working Capital
| -12.657 | -2.744 | -2.233 | -4.566 | -20.622 | -21.921 | 4.867 | -2.629 | -1.316 | 4.209 |
| Other Non Cash Items
| 37.189 | 32.978 | -15.008 | -54.371 | -8.558 | -12.432 | -3.562 | -5.16 | -28.168 | -132.228 |
| Operating Cash Flow
| 35.939 | 40.481 | 44.618 | -12.205 | 4.596 | -5.739 | 23.457 | 14.738 | 7.636 | 0.803 |
| Investing Activities: | ||||||||||
| Investments In Property Plant And Equipment
| -9.958 | -25.816 | -224.183 | -20.668 | -2.948 | -3.872 | -0.126 | -9.86 | -1.75 | -0.07 |
| Acquisitions Net
| 0 | 0 | -220.351 | -170.855 | -172.306 | 3.288 | 0 | 2.157 | -0.217 | 139.564 |
| Purchases Of Investments
| -334.163 | -185.473 | -64.321 | -53.941 | -247.667 | -586.489 | -338.611 | -568.559 | -610.279 | -149.808 |
| Sales Maturities Of Investments
| 347.901 | 150.544 | 180.541 | 269.378 | 422.567 | 302.31 | 280.022 | 558.994 | 543.007 | 0.17 |
| Other Investing Activites
| 25.561 | -2.334 | 223.035 | 77.439 | -11.506 | 32.449 | 18.723 | -31.95 | 2.155 | -38.941 |
| Investing Cash Flow
| 29.341 | -63.079 | -105.279 | 101.353 | -11.86 | -252.314 | -39.992 | -49.218 | -67.084 | -49.085 |
| Financing Activities: | ||||||||||
| Debt Repayment
| -18.024 | 31.491 | -14.192 | 6.728 | -8.612 | 0 | 0 | 0 | 0 | -0.595 |
| Common Stock Issued
| 0 | 0 | 0 | 0 | 0 | 0.29 | 0.746 | 313.574 | 12.501 | 83.066 |
| Common Stock Repurchased
| -53.479 | -30.069 | -64.415 | -36.787 | -54.838 | 0 | 0 | -0.35 | 0 | -0.595 |
| Dividends Paid
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -247.75 |
| Other Financing Activities
| -9.499 | -4.179 | 0.297 | 0.826 | 0.655 | 0.29 | 0.746 | 0.105 | 1.361 | 246.845 |
| Financing Cash Flow
| -81.002 | 1.762 | -78.31 | -29.233 | -62.795 | 0.29 | 0.746 | 313.329 | 13.862 | 328.721 |
| Other Information: | ||||||||||
| Effect Of Forex Changes On Cash
| 2.804 | 6.552 | -4.658 | -4.592 | -0.458 | 6.088 | -2.693 | -1.388 | -0.378 | 3.006 |
| Net Change In Cash
| -12.918 | -14.284 | -143.629 | 55.324 | -70.517 | -251.675 | -18.482 | 277.461 | -45.964 | 283.445 |
| Cash At End Of Period
| 58.761 | 71.679 | 85.963 | 229.592 | 174.268 | 244.785 | 496.46 | 514.942 | 237.481 | 283.445 |